SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Ruel Marc)
 

Sökning: WFRF:(Ruel Marc) > (2006-2009) > Tissue-engineered i...

Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+progenitors expanded from the peripheral blood

Suuronen, Erik J. (författare)
Division of Cardiac Surgery, University of Ottawa, Ottawa, Ontario, Canada
Veinot, John P. (författare)
Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada
Wong, Serena (författare)
Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
visa fler...
Kapila, Varun (författare)
Division of Cardiac Surgery, University of Ottawa, Ottawa, Ontario, Canada
Price, Joel (författare)
Division of Cardiac Surgery, University of Ottawa, Ottawa, Ontario, Canada
Griffith, May (författare)
Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
Mesana, Thierry G. (författare)
Division of Cardiac Surgery, University of Ottawa, Ottawa, Ontario, Canada
Ruel, Marc (författare)
Division of Cardiac Surgery and Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
visa färre...
 (creator_code:org_t)
LIPPINCOTT WILLIAMS and WILKINS, 2006
2006
Engelska.
Ingår i: Circulation. - : LIPPINCOTT WILLIAMS and WILKINS. - 0009-7322 .- 1524-4539. ; 114, s. I138-I144
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background-The use of stem and/or progenitor cells to achieve potent vasculogenesis in humans has been hindered by low cell numbers, implant capacity, and survival. This study investigated the expansion of CD133(+) cells and the use of an injectable collagen-based tissue engineered matrix to support cell delivery and implantation within target ischemic tissue. Methods and Results-Adult human CD133(+) progenitor cells from the peripheral blood were generated and expanded by successive removal and culture of CD133(-) cell fractions, and delivered within an injectable collagen-based matrix into the ischemic hindlimb of athymic rats. Controls received injections of phosphate-buffered saline, matrix, or CD133(+) cells alone. Immunohistochemistry of hindlimb muscle 2 weeks after treatment revealed that the number of CD133(+) cells retained within the target site was greater than 2-fold greater when delivered by matrix than when delivered alone (P less than 0.01). The transplanted CD133(+) cells incorporated into vascular structures, and the matrix itself also was vascularized. Rats that received matrix and CD133(+) cells demonstrated greater intramuscular arteriole and capillary density than other treatment groups (P less than 0.05 and P less than 0.01, respectively). Conclusions-Compared with other experimental approaches, treatment of ischemic muscle tissue with generated CD133(+) progenitor cells delivered in an injectable collagen-based matrix significantly improved the restoration of a vascular network. This work demonstrates a novel approach for the expansion and delivery of blood CD133(+) cells with resultant improvement of their implantation and vasculogenic capacity.

Nyckelord

angiogenesis; cells; endothelial progenitor cells; ischemia; revascularization; tissue engineering
MEDICINE
MEDICIN

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy